FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gerasimos Aravantinos

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Concepts & Ideas

Disorders

Physiology

Disease Progression

Geographic Areas

Greece

Co-author Network

Publications

TOP 3
Aristotelis Bamias; M Chrisophos; C Constantinidis; Urania Dafni; C Deliveliotis; Gerasimos Aravantinos; A Eleftheraki; George Fountzilas; C Hatzimouratidis; A Karadimou; V Koutoulidis; Dimitrios Pectasides; A Psyrri; Epaminondas Samantas; K Stravodimos; Eleni Timotheadou; Marinos L Tsiatas; A Visvikis; Ioannis Xanthakis; Meletios A Dimopoulos
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).
Niki Mourouti; Gerasimos Aravantinos; Evangelos Filopoulos; Nikolaos Malamos; Aikaterini Manousou; Christos Papavagelis; Petrini Plytzanopoulou; Theodora Psaltopoulou; Epaminondas Samantas; Tonia Vassilakou; Demosthenes B Panagiotakos
Aims, design and methods of a case-control study for the assessment of the role of dietary habits, eating behaviors and environmental factors, on the development of breast cancer.
Evangelia Razis; Despina Televantou; Eleni Timotheadou; Ralph M Wirtz; Gerasimos Aravantinos; Dimitrios Bafaloukos; Christos Christodoulou; Anastasia G Eleftheraki; Helen Gogas; Konstantine T Kalogeras; Vassiliki Kotoula; Ralf Kronenwett; Thomas Makatsoris; Nikitas Nikitas; Nicholas Pavlidis; Dimitrios Pectasides; George Fountzilas
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gerasimos Aravantinos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Aristotelis Bamias; M Chrisophos; C Constantinidis; Urania Dafni; C Deliveliotis; Gerasimos Aravantinos; A Eleftheraki; George Fountzilas; C Hatzimouratidis; A Karadimou; V Koutoulidis; Dimitrios Pectasides; A Psyrri; Epaminondas Samantas; K Stravodimos; Eleni Timotheadou; Marinos L Tsiatas; A Visvikis; Ioannis Xanthakis; Meletios A Dimopoulos
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(4):1011-7.
2013: Niki Mourouti; Gerasimos Aravantinos; Evangelos Filopoulos; Nikolaos Malamos; Aikaterini Manousou; Christos Papavagelis; Petrini Plytzanopoulou; Theodora Psaltopoulou; Epaminondas Samantas; Tonia Vassilakou; Demosthenes B Panagiotakos
Aims, design and methods of a case-control study for the assessment of the role of dietary habits, eating behaviors and environmental factors, on the development of breast cancer.
Maturitas 2013;74(1):31-6.
2012: Evangelia Razis; Despina Televantou; Eleni Timotheadou; Ralph M Wirtz; Gerasimos Aravantinos; Dimitrios Bafaloukos; Christos Christodoulou; Anastasia G Eleftheraki; Helen Gogas; Konstantine T Kalogeras; Vassiliki Kotoula; Ralf Kronenwett; Thomas Makatsoris; Nikitas Nikitas; Nicholas Pavlidis; Dimitrios Pectasides; George Fountzilas
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
Clinical breast cancer 2012;12(3):183-93.
2012: A Psyrri; Eleni Timotheadou; R M Wirtz; Gerasimos Aravantinos; A Batistatou; E Bournakis; C Christodoulou; T Economopoulos; Helen Gogas; K T Kalogeras; R Kronenwett; Helena Linardou; Thomas Makatsoris; N Pavlidis; Dimitrios Pectasides; G Fountzilas
Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(6):1422-7.
2012: P Skarlos; D Televantou; Eleni Timotheadou; O Tzaida; Christos Valavanis; R M Wirtz; P Arapantoni; Gerasimos Aravantinos; A Batistatou; Mattheos Bobos; Christos Christodoulou; A G Eleftheraki; Helen Gogas; K T Kalogeras; Ioannis Kostopoulos; E Koutselini; R Kronenwett; Christos A Papadimitriou; I Papaspirou; N Pavlidis; Dimitrios Pectasides; Dimosthenis V Skarlos; George Fountzilas
Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.
Cancer chemotherapy and pharmacology 2012;69(2):533-46.
2012: George Fountzilas; Helen Gogas; Konstantine T Kalogeras; Vassiliki Kotoula; Angelos Koutras; Ralf Kronenwett; Dimitrios Pectasides; George Pentheroudakis; Genovefa Polychronidou; Nikolaos Soupos; Eleni Timotheadou; Olympia Tzaida; Christos Valavanis; Dimitrios Vlachodimitropoulos; Ralph M Wirtz; Gerasimos Aravantinos; Anna Batistatou; Mattheos Bobos; Christos Christodoulou; Anastasia G Eleftheraki; Petroula Arapantoni
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.
Journal of translational medicine 2012;10():10.
2012: Dimitrios Pectasides; Dimosthenis Skarlos; Ioannis Varthalitis; Gerasimos Aravantinos; Dimitrios Bafaloukos; Evangelos Bournakis; Athanassios Meletios Dimopoulos; Helen Fountzilas; Haralabos P Kalofonos; Konstantine T Kalogeras; Ippokratis Korantzis; Paris Kosmidis; Vassiliki Kotoula; Angelos Koutras; Pavlos Papakostas; George Papaxoinis; George Fountzilas
Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.
Oncology reports 2012;27(1):216-24.
2011: Evangelia Razis; G Rigakos; Dimosthenis Skarlos; Gerasimos Aravantinos; Dimitrios Bafaloukos; Mattheos Bobos; Ioannis Efstratiou; A G Eleftheraki; Haralabos P Kalofonos; K T Kalogeras; Ioannis Kostopoulos; Vassiliki Kotoula; Pavlos Papakostas; Kitty Pavlakis; Dimitrios Pectasides; K Petraki; George Fountzilas
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.
Breast cancer research and treatment 2011;128(2):447-56.
2011: Dimitrios J Stravopodis; Panagiotis Karkoulis; Eumorphia G Konstantakou; Sophia Melachroinou; Angeliki Thanasopoulou; Gerasimos Aravantinos; Lukas H Margaritis; Ema Anastasiadou; Gerassimos E Voutsinas
Thymidylate synthase inhibition induces p53-dependent and p53-independent apoptotic responses in human urinary bladder cancer cells.
Journal of cancer research and clinical oncology 2011;137(2):359-74.
2011: Christos A Papadimitriou; Pavlos Papakostas; Maria Karina; Lia Malettou; Meletios A Dimopoulos; George Pentheroudakis; Epaminondas Samantas; Aristotelis Bamias; Dimosthenis Miliaras; George Basdanis; Nikolaos Xiros; George Klouvas; Dimitrios Bafaloukos; Georgia Kafiri; Irene Papaspirou; Dimitrios Pectasides; Charisios Karanikiotis; Theofanis Economopoulos; Ioannis Efstratiou; Ippokratis Korantzis; Nikolaos Pisanidis; Thomas Makatsoris; Fotini Matsiakou; Gerasimos Aravantinos; Haralabos P Kalofonos; George Fountzilas
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group study.
BMC medicine 2011;9():10.
2010: Dimitrios Bafaloukos; Helena Linardou; Gerasimos Aravantinos; Christos Papadimitriou; Aristotelis Bamias; George Fountzilas; Haralabos P Kalofonos; Paris Kosmidis; Eleni Timotheadou; Thomas Makatsoris; Epaminondas Samantas; Evangelos Briasoulis; Christos Christodoulou; Pavlos Papakostas; Dimitrios Pectasides; Athanasios M Dimopoulos
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.
BMC medicine 2010;8():3.
2009: Eumorphia G Konstantakou; Gerassimos E Voutsinas; Panagiotis Karkoulis; Gerasimos Aravantinos; Lukas H Margaritis; Dimitrios J Stravopodis
Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses.
International journal of oncology 2009;35(2):401-16.
2009: Giannis Mountzios; Meletios A Dimopoulos; Aristotelis Bamias; G Vourli; Haralambos Kalofonos; Gerasimos Aravantinos; George Fountzilas; Christos A Papadimitriou
Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1362-8.
2009: George Fountzilas; Urania Dafni; Meletios A Dimopoulos; A Koutras; Dimosthenis Skarlos; Pavlos Papakostas; Helen Gogas; Dimitrios Bafaloukos; Anna Kalogera-Fountzila; Epaminondas Samantas; Evangelos Briasoulis; Dimitrios Pectasides; N Maniadakis; F Matsiakou; Gerasimos Aravantinos; Christos Papadimitriou; Maria Karina; Christos Christodoulou; Paris A Kosmidis; Haralabos P Kalofonos
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.
Breast cancer research and treatment 2009;115(1):87-99.
2009: Dimitrios Pectasides; George Papaxoinis; George Fountzilas; Gerasimos Aravantinos; A Bamias; N Pavlidis; H P Kalofonos; E Timotheadou; E Samantas; E Briasoulis; D V Skarlos; Theofanis Economopoulos; M A Dimopoulos
Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Anticancer research 2009;29(2):745-51.
2009: Dimitrios Pectasides; George Papaxoinis; Maria Nikolaou; Christos Valavanis; Gerasimos Aravantinos; George Fountzilas; Nikolaos Tamvakis; Eirini Pectasides; I Lekka; Petroula Arapantoni-Dadioti; A Zizi; I Ghiconti; Theofanis Economopoulos
Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1.
Anticancer research 2009;29(2):737-44.
2009: George Fountzilas; Anna Kalogera-Fountzila; Sophia Lambaki; Ralph M Wirtz; Angelos Nikolaou; Georgia Karayannopoulou; Mattheos Bobos; Vassiliki Kotoula; Samuel Murray; Alexandros Lambropoulos; Gerasimos Aravantinos; Konstantinos Markou; Eleni Athanassiou; Despina Misailidou; Konstantine T Kalogeras; Dimosthenis Skarlos
MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.
Journal of oncology 2009;2009():305908.
2009: Dimosthenis V Skarlos; Eleni Timotheadou; Eleni Galani; Epaminondas Samantas; Irene Grimani; Evangelos Lianos; Gerasimos Aravantinos; Ioannis Xanthakis; George Pentheroudakis; Dimitrios Pectasides; George Fountzilas
Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology Group.
Oncology 2009;77(2):107-12.
2008: Angelos Koutras; K T Kalogeras; Meletios A Dimopoulos; R M Wirtz; U Dafni; E Briasoulis; Dimitrios Pectasides; Helen Gogas; C Christodoulou; Gerasimos Aravantinos; G Zografos; E Timotheadou; Pavlos Papakostas; H Linardou; E Razis; Theofanis Economopoulos; Haralabos P Kalofonos; G Fountzilas
Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
British journal of cancer 2008;99(11):1775-85.
2008: Gerasimos Aravantinos; George Fountzilas; Aristotelis Bamias; Irene Grimani; Spyridon Rizos; Haralabos P Kalofonos; Dimosthenis V Skarlos; Theofanis Economopoulos; Paris A Kosmidis; George P Stathopoulos; Evangelos Briasoulis; Dimitrios Pectasides; Epaminondas Samantas; Eleni Timotheadou; Christos Papadimitriou; Alexandros Papanikolaou; Adimchi Onyenadum; Pavlos Papakostas; Dimitrios Bafaloukos; Meletios A Dimopoulos
Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
European journal of cancer (Oxford, England : 1990) 2008;44(15):2169-77.
2008: Christos A Papadimitriou; George Fountzilas; Dimitrios Bafaloukos; George Bozas; Haralambos Kalofonos; Dimitrios Pectasides; Gerasimos Aravantinos; Aristotelis Bamias; Meletios A Dimopoulos
Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
Gynecologic oncology 2008;111(1):27-34.
2008: Christos A Papadimitriou; Dimitrios Bafaloukos; George Bozas; Haralambos Kalofonos; Paris Kosmidis; Gerasimos Aravantinos; George Fountzilas; Meletios A Dimopoulos
Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
Gynecologic oncology 2008;110(1):87-92.
2008: Evangelos Briasoulis; George Fountzilas; A Bamias; M A Dimopoulos; N Xiros; Gerasimos Aravantinos; Epaminondas Samantas; H Kalofonos; T Makatsoris; N Mylonakis; P Papakostas; D Skarlos; I Varthalitis; Nicholas Pavlidis
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.
Cancer chemotherapy and pharmacology 2008;62(2):277-84.
2008: Christos A Papadimitriou; Pavlos Papakostas; Eleni Timotheadou; Gerasimos Aravantinos; Aristotelis Bamias; George Fountzilas
Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF and weekly paclitaxel in patients with resected high-risk breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
Cancer investigation 2008;26(5):491-8.
2008: George Pentheroudakis; George Fountzilas; Haralabos P Kalofonos; Vassilios Golfinopoulos; Gerasimos Aravantinos; Dimitrios Bafaloukos; Pavlos Papakostas; Dimitrios Pectasides; Christos Christodoulou; Konstantinos Syrigos; Theofanis Economopoulos; Nicholas Pavlidis
Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Critical reviews in oncology/hematology 2008;66(3):237-47.
2008: Dimitrios Pectasides; George Papaxoinis; George Fountzilas; Gerasimos Aravantinos; Eirini Pectasides; Despina Mouratidou; Theofanis Economopoulos; Ch Andreadis
Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG).
Anticancer research 2008;28(2B):1421-7.
2008: Christos Papadimitriou; U Dafni; Athanasios Anagnostopoulos; George Vlachos; Zannis Voulgaris; Alexandros Rodolakis; Gerasimos Aravantinos; Aristotelis Bamias; George Bozas; E Kiosses; G M Gourgoulis; Eleni Efstathiou; Meletios A Dimopoulos
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial.
Bone marrow transplantation 2008;41(6):547-54.
2008: Dimitrios Pectasides; Nikolaos Xiros; George Papaxoinis; Gerasimos Aravantinos; Constantinos Sykiotis; Eirini Pectasides; Amanda Psyrri; ANNA KOUMARIANOU; Asimina Gaglia; Panagiotis Gouveris; Theofanis Economopoulos
Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma.
Gynecologic oncology 2008;108(1):47-52.
2007: Aristotelis Bamias; Gerasimos Aravantinos; Charalambos Deliveliotis; Anastasios Thanos; George Klouvas; Nikolaos Antoniou; Iraklis Poulias; Thomas Makatsoris; Epaminondas Samantas; Meletios A Dimopoulos
Two cycles of etoposide/cisplatin cured all patients with stage I testicular seminoma: risk-adapted protocol of the Hellenic Cooperative Oncology Group.
Urology 2007;70(6):1179-83.
2007: Dimitrios Pectasides; Urania Dafni; Gerasimos Aravantinos; Eleni Timotheadou; Dimosthenis V Skarlos; N Pavlidis; Asimina Gaglia; Haralabos P Kalofonos; George Fountzilas
A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin.
Anticancer research 2007;27(6C):4411-7.
2007: Adimchi Onyenadum; Helen Gogas; Christos Markopoulos; Dimitrios Bafaloukos; Gerasimos Aravantinos; Marina Mantzourani; Angelos Koutras; E Tzorakoelefterakis; Nikolaos Xiros; Thomas Makatsoris; George Fountzilas; Haralabos P Kalofonos
Mitoxantrone plus vinorelbine in pretreated patients with metastatic breast cancer.
Journal of chemotherapy (Florence, Italy) 2007;19(5):582-9.
2007: Savvas Papadopoulos; George Kouvatseas; Dimosthenis Skarlos; Nikolaos Malamos; Eleftheria Delliou; Ioanna Saratsiotou; Alexandros Ardavanis; Dimitrios Mavroudis; Eva Skarpidi; Petroula Arapantoni; Irini Karyda; Frideriki Patakioyta; Gerasimos Aravantinos; Evangelia Razis; George Fountzilas; Paris A Kosmidis
Comparison of HER2 detection methods between central and regional laboratories in Greece.
Clinical breast cancer 2007;7(10):784-90.
2007: George P Stathopoulos; Nikolaos Malamos; Gerasimos Aravantinos; Sotiris K Rigatos; Ch Christodoulou; John G Stathopoulos; Dimosthenis Skarlos
Weekly administration of topotecan-paclitaxel as second-line treatment in ovarian cancer.
Cancer chemotherapy and pharmacology 2007;60(1):123-8.
2007: Maria Nikolaou; Christos Valavanis; Gerasimos Aravantinos; George Fountzilas; Nikolaos Tamvakis; I Lekka; Petroula Arapantoni-Dadioti; A Zizi; I Ghiconti; Theofanis Economopoulos; Dimitrios Pectasides
Kit expression in male germ cell tumors.
Anticancer research 2007;27(3B):1685-8.
2007: Vassiliki Malamou-Mitsi; Olga Crikoni; Eleni Timotheadou; Gerasimos Aravantinos; Eleni Vrettou; Niki J Agnantis; George Fountzilas
Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer.
Anticancer research 2007;27(2):1157-65.
2007: Paris A Kosmidis; Meletios A Dimopoulos; Konstantinos Syrigos; Costas Nicolaides; Gerasimos Aravantinos; Ioannis Boukovinas; Dimitrios Pectasides; George Fountzilas; Dimitrios Bafaloukos; Christos Bacoyiannis; Haralabos P Kalofonos
Gemcitabine versus gemcitabine-carboplatin for patients with advanced non-small cell lung cancer and a performance status of 2: a prospective randomized phase II study of the Hellenic Cooperative Oncology Group.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(2):135-40.
2007: Dimitrios Pectasides; Christos Valavanis; Maria Nikolaou; Gerasimos Aravantinos; I Lekka; Dimosthenis Skarlos; Charalambos Kalofonos; George Fountzilas; Vassiliki Kostopoulou; A Zizi; Theofanis Economopoulos; P Arapantoni-Datioti
Molecular markers in extragonadal germ cell tumours: a matched case-control study.
Histopathology 2007;50(3):394-6.
2007: Olympia Tzaida; Helen Gogas; Urania Dafni; Aspasia Kyroudi; IA Papaspyrou; Vasiliki Kyriakou; Vasiliki Malamou-Mitsi; Maria Alamani; Chrisoula Skopa; Ioannis Kostopoulos; Efstathios Kastritis; Dimitrios Pectasides; Evangelos Briasoulis; Haralabos P Kalofonos; Gerasimos Aravantinos; George Fountzilas; Petroula Arapantoni-Dadioti
Evaluation of the prognostic and predictive value of HER-1/EGFR in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Oncology 2007;72(5-6):388-96.
2007: Thomas Makatsoris; Pavlos Papakostas; Haralabos P Kalofonos; Ioannis Xanthakis; Dimitrios Tsavdaridis; Gerasimos Aravantinos; Helen Gogas; George Klouvas; Paris A Kosmidis; Dimitrios Pectasides; George Fountzilas
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study.
Medical oncology (Northwood, London, England) 2007;24(3):301-7.
2006: George Fountzilas; Pavlos Papakostas; Urania Dafni; Thomas Makatsoris; Maria Karina; Anna Kalogera-Fountzila; N Maniadakis; Gerasimos Aravantinos; Konstantinos Syrigos; Aristotelis Bamias; Christos Christodoulou; Theofanis Economopoulos; Haralambos Kalofonos; Angelos Nikolaou; N Angouridakis; George P Stathopoulos; Dimitrios Bafaloukos; Nicholas Pavlidis; John Daniilidis
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(10):1560-7.
2006: George P Stathopoulos; Konstantinos Syrigos; Gerasimos Aravantinos; Aristidis Polyzos; Pavlos Papakotoulas; G Fountzilas; Anna Potamianou; Nikolaos Ziras; John Boukovinas; John Varthalitis; Nikolaos Androulakis; Athanasios Kotsakis; George Samonis; Vassilis Georgoulias
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.
British journal of cancer 2006;95(5):587-92.
2006: Dimitrios Pectasides; George Fountzilas; Gerasimos Aravantinos; Charalambos Kalofonos; Helen Efstathiou; Dimitrios Farmakis; Dimosthenis Skarlos; Nicholas Pavlidis; Theofanis Economopoulos; Meletios A Dimopoulos
Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2006;102(2):285-91.
2006: Adimchi Onyenadum; Helen Gogas; Paris A Kosmidis; Gerasimos Aravantinos; Dimitrios Bafaloukos; H Bacoyiannis; Christos Markopoulos; Angelos Koutras; E Tzorakoelefterakis; Thomas Makatsoris; George Fountzilas; Haralabos P Kalofonos
Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancer.
Journal of chemotherapy (Florence, Italy) 2006;18(2):192-8.
2006: Aristotelis Bamias; Lia A Moulopoulos; Angelos Koutras; Gerasimos Aravantinos; George Fountzilas; Dimitrios Pectasides; Efstathios Kastritis; Dimitra Gika; Dimosthenis Skarlos; Helena Linardou; Haralabos P Kalofonos; Meletios A Dimopoulos
The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.
Cancer 2006;106(2):297-303.
2006: Nikolaos Androulakis; Gerasimos Aravantinos; Konstantinos Syrigos; Aristidis Polyzos; Nikolaos Ziras; Evangelos Tselepatiotis; George Samonis; Nikolaos Kentepozidis; Stylianos Giassas; Lambros Vamvakas; Vassilis Georgoulias
Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: a multicenter phase II study.
Oncology 2006;70(4):280-4.
2006: Aristotelis Bamias; Christos Papadimitriou; Eleni Efstathiou; Alexandros Rodolakis; George Vlahos; Zannis Voulgaris; George Bozas; George Fountzilas; Gerasimos Aravantinos; Evangelia Razis; Dimitra Gika; Meletios A Dimopoulos
Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
BMC cancer 2006;6():228.
2005: George Fountzilas; Dimosthenis Skarlos; Urania Dafni; Helen Gogas; Evangelos Briasoulis; Dimitrios Pectasides; Christos Papadimitriou; Christos Markopoulos; A Polychronis; Haralabos P Kalofonos; V Siafaka; Paris A Kosmidis; Eleni Timotheadou; Dimitrios Tsavdaridis; Dimitrios Bafaloukos; Pavlos Papakostas; Evangelia Razis; P Makrantonakis; Gerasimos Aravantinos; Christos Christodoulou; Athanassios Meletios Dimopoulos
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1762-71.
2005: Dimitrios Pectasides; Gerasimos Aravantinos; George Fountzilas; Charalambos Kalofonos; Eleni Efstathiou; Maria Karina; Nicholas Pavlidis; Dimitrios Farmakis; Theofanis Economopoulos; Meletios A Dimopoulos
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.
Anticancer research 2005;25(5):3553-8.
2005: Georgios Fotios Samelis; Haralambos Kalofonos; Adamos Adamou; Paris Kosmides; Dimosthenis Skarlos; Gerasimos Aravantinos; Christos Kiamouris; Oneynadum Adimchi; George Fountzilas; Athanassios Meletios Dimopoulos
The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: a Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
Urology 2005;66(2):382-5.
2005: Eleni Timotheadou; Pavlos Papakostas; Dimitrios Tsavdaridis; George Basdanis; Haralambos Kalofonos; Gerasimos Aravantinos; Dimitrios Bafaloukos; George Fountzilas
Irinotecan and oxaliplatin combination, as second-line treatment, in fluoropyrimidine-pretreated advanced colorectal cancer. A phase II study by the Hellenic Cooperative Oncology Group (HeCOG).
Tumori 2005;91(4):309-13.
2005: Dimosthenis V Skarlos; Haralabos P Kalofonos; George Fountzilas; Meletios A Dimopoulos; Nicholas Pavlidis; Evangelia Razis; Theofanis Economopoulos; Dimitrios Pectasides; Helen Gogas; Paris A Kosmidis; Dimitrios Bafaloukos; George Klouvas; George Kyratzis; Gerasimos Aravantinos
Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.
Anticancer research 2005;25(4):3103-8.
2005: Gerasimos Aravantinos; George Fountzilas; Paris A Kosmidis; Meletios A Dimopoulos; George P Stathopoulos; Nicholas Pavlidis; Dimitrios Bafaloukos; Christos Papadimitriou; S Karpathios; Vassilis Georgoulias; Pavlos Papakostas; Haralabos P Kalofonos; E Grimani; Dimosthenis V Skarlos
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1116-22.
2005: Haralabos P Kalofonos; Gerasimos Aravantinos; Paris A Kosmidis; Pavlos Papakostas; Theofanis Economopoulos; Meletios A Dimopoulos; Dimosthenis Skarlos; Aristotelis Bamias; Dimitrios Pectasides; S Chalkidou; Maria Karina; Angelos Koutras; Epaminondas Samantas; Christos Bacoyiannis; Georgios Fotios Samelis; George Basdanis; Fotis Kalfarentzos; George Fountzilas
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(6):869-77.
2005: Dimitrios Pectasides; George Fountzilas; Gerasimos Aravantinos; Haralabos P Kalofonos; Eleni Efstathiou; Emmanuel Salamalekis; Dimitrios Farmakis; Dimosthenis Skarlos; Evangelos Briasoulis; Theofanis Economopoulos; Meletios A Dimopoulos
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2005;97(2):436-41.
2005: Thomas Makatsoris; Haralabos P Kalofonos; Gerasimos Aravantinos; Christos Papadimitriou; Efstathios Kastritis; Sotiris K Rigatos; Nikolaos Xiros; Theodore Petsas; Theofanis Economopoulos; Athanassios K Sakadamis; George Fountzilas
A phase II study of capecitabine plus oxaliplatin (XELOX): a new first-line option in metastatic colorectal cancer.
International journal of gastrointestinal cancer 2005;35(2):103-9.
2005: Nikolaos Androulakis; Konstantinos Syrigos; Aristidis Polyzos; Gerasimos Aravantinos; George P Stathopoulos; Nikolaos Ziras; Konstantinos Mallas; Lambros Vamvakas; Vassilis Georgoulis
Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II study.
Cancer investigation 2005;23(1):9-12.
2005: Christos Christodoulou; Dimitrios Bafaloukos; Helena Linardou; Gerasimos Aravantinos; Aristotelis Bamias; Maria Carina; George Klouvas; Dimosthenis Skarlos
Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.
Journal of neuro-oncology 2005;71(1):61-5.
2004: Meletios A Dimopoulos; Christos Papadimitriou; George Hamilos; Eleni Efstathiou; George Vlahos; Alexandros Rodolakis; Gerasimos Aravantinos; Haralambos Kalofonos; Charalambos Kouroussis; Dimitra Gika; Dimosthenis Skarlos; Aristotelis Bamias
Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
Gynecologic oncology 2004;95(3):695-700.
2004: Dimitrios Bafaloukos; Christos Papadimitriou; Helena Linardou; Gerasimos Aravantinos; Pavlos Papakostas; Dimosthenis Skarlos; Paris A Kosmidis; George Fountzilas; Helen Gogas; Charalambos Kalofonos; Athanassios Meletios Dimopoulos
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group.
British journal of cancer 2004;91(9):1639-44.
2004: George Fountzilas; Haralabos P Kalofonos; Urania Dafni; Christos Papadimitriou; Dimitrios Bafaloukos; Pavlos Papakostas; Anna Kalogera-Fountzila; Helen Gogas; Gerasimos Aravantinos; Lia A Moulopoulos; Theofanis Economopoulos; Dimitrios Pectasides; N Maniadakis; V Siafaka; Evangelos Briasoulis; Christos Christodoulou; Dimitrios Tsavdaridis; P Makrantonakis; Evangelia Razis; Paris A Kosmidis; Dimosthenis Skarlos; Meletios A Dimopoulos
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1517-26.
2004: Helena Linardou; Gerasimos Aravantinos; Eleni Efstathiou; Charalambos Kalofonos; Athanasios Anagnostopoulos; Charalambos Deliveliotis; Dimitrios Bafaloukos; Meletios Athanasios Dimopoulos; Aristotelis Bamias
Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group.
Urology 2004;64(3):479-84.
2004: Dimitrios Pectasides; Melina Pectasides; Dimitrios Farmakis; Gerasimos Aravantinos; Maria Nikolaou; Maria Koumpou; Asimina Gaglia; Vassiliki Kostopoulou; Nicolas Mylonakis; Theofanis Economopoulos; Sotirios A Raptis
Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase II study.
European urology 2004;46(2):216-21.
2004: Jim Janinis; George P Stathopoulos; Pavlos Nikolaidis; Haralabos P Kalofonos; Anna Kalogera-Fountzila; Epaminondas Samantas; Gerasimos Aravantinos; Athanassios Anagnostopoulos; Christos Tolis; Thomas Makatsoris; Sotiris K Rigatos; Dimitrios Bafaloukos; Meletios A Dimopoulos; John Daniilidis; George Fountzilas
Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Anti-cancer drugs 2004;15(5):479-87.
2004: Helen Gogas; Dimitrios Bafaloukos; John Ioannovich; Dimosthenis Skarlos; Aristidis Polyzos; George Fountzilas; Haralabos P Kalofonos; Gerasimos Aravantinos; Dimosthenis A Tsoutsos; Petros Panagiotou; Konstantina Frangia; Theodora Petrakopoulou; Dimitrios Pectasides
Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study.
Anticancer research 2004;24(3b):1947-52.
2004: Aristotelis Bamias; Charalambos Deliveliotis; Gerasimos Aravantinos; Charalambos Kalofonos; Aristidis Karayiannis; Meletios A Dimopoulos
Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced bladder cancer: a study by the Hellenic Cooperative Oncology Group.
The Journal of urology 2004;171(4):1467-70.
2004: Dimitrios Pectasides; Melina Pectasides; Dimitrios Farmakis; Gerasimos Aravantinos; Maria Nikolaou; Maria Koumpou; Asimina Gaglia; Vassiliki Kostopoulou; Nicolas Mylonakis; Dimosthenis Skarlos
Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(3):493-7.
2004: George P Stathopoulos; Konstantinos Syrigos; Aristidis Polyzos; G Fountzilas; Sotiris K Rigatos; Nikolaos Ziras; A Potamiannou; I Tsiakopoulos; Nikolaos Androulakis; Gerasimos Aravantinos; Athanasios Athanasiadis; Pavlos Papakotoulas; Vassilis Georgoulias
Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):224-9.
2004: Aristotelis Bamias; Gerasimos Aravantinos; Charalambos Deliveliotis; Dimitrios Bafaloukos; Charalambos Kalofonos; Nikolaos Xiros; Anastasios Zervas; Dionisios Mitropoulos; Epaminondas Samantas; Dimitrios Pectasides; Pavlos Papakostas; Dimitra Gika; Charalabos Kourousis; Angelos Koutras; Christos Papadimitriou; C Bamias; Paris A Kosmidis; Meletios A Dimopoulos
Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(2):220-8.
2004: Helen Gogas; Dimitrios Bafaloukos; Gerasimos Aravantinos; George Fountzilas; Dimosthenis A Tsoutsos; Petros Panagiotou; Konstantina Frangia; Haralabos P Kalofonos; E Briasoulis; Ourania Castana; Aristidis Polyzos; Dimitrios Pectasides; John Ioannovich
Vinorelbine in combination with interleukin-2 as second-line treatment in patients with metastatic melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
Cancer investigation 2004;22(6):832-9.
2004: George Fountzilas; Christos Christodoulou; Dimitrios Tsavdaridis; Anna Kalogera-Fountzila; Gerasimos Aravantinos; Evangelia Razis; Haralabos P Kalofonos; Pavlos Papakostas; Maria Karina; Helen Gogas; Dimosthenis Skarlos
Paclitaxel and gemcitabine, as first-line chemotherapy, combined with trastuzumab in patients with advanced breast cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG).
Cancer investigation 2004;22(5):655-62.
2004: Evangelia Razis; Paris A Kosmidis; Gerasimos Aravantinos; Charalambos Bakoyiannis; Jim Janinis; Helen Timotheadou; Christos Christodoulou; George Fountzilas
Second line chemotherapy with 5 fluorouracil and vinorelbine in anthracycline and taxane pretreated patients with metastatic breast cancer.
Cancer investigation 2004;22(1):10-5.
2004: Christos A Papadimitriou; George Fountzilas; Gerasimos Aravantinos; Charalambos Kalofonos; Lia A Moulopoulos; Evangelos Briassoulis; Dimitra Gika; Meletios A Dimopoulos
Second-line chemotherapy with gemcitabine and carboplatin in paclitaxel-pretreated, platinum-sensitive ovarian cancer patients. A Hellenic Cooperative Oncology Group Study.
Gynecologic oncology 2004;92(1):152-9.
2003: Dimitrios Pectasides; Dimosthenis Skarlos; Athanassios Meletios Dimopoulos; Dimitrios Farmakis; Melina Pectasides; George Fountzilas; Gerasimos Aravantinos
Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial.
Anticancer research 2003;23(5b):4239-44.
2003: Gerasimos Aravantinos; Dimitrios Bafaloukos; G Fountzilas; C Christodoulou; Christos Papadimitriou; Nicholas Pavlidis; H P Kalofonos; H Gogas; Paris A Kosmidis; Meletios A Dimopoulos
Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(7):1094-9.
2003: Georgios Fotios Samelis; Dimosthenis Skarlos; D Bafaloukos; Paris A Kosmidis; A Anagnostopoulos; Gerasimos Aravantinos; Meletios A Dimopoulos
The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group.
Urology 2003;61(6):1211-5.
2003: Gerasimos Aravantinos; Helena Linardou; D Makridaki; E Laiou; A Zafiropoulos; J Janninis; G Sofos; D Gikas; Epaminondas Samantas; S Markantoni-Kyroudi
Recombinant human erythropoietin for platinum-based chemotherapy-induced anaemia: A single-centre randomised study.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2003;8(2):127-32.
2003: George P Stathopoulos; Sotiris K Rigatos; M A Dimopoulos; THEODORE GIANNAKAKIS; G Foutzilas; Charalambos Kouroussis; D Janninis; Gerasimos Aravantinos; Nikolaos Androulakis; Sofia Agelaki; John G Stathopoulos; Vassilis Georgoulias
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):388-94.
2003: Jim Janinis; M Patriki; L Vini; Gerasimos Aravantinos; Jeremy S Whelan
The pharmacological treatment of aggressive fibromatosis: a systematic review.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):181-90.
2003: Aristotelis Bamias; Gerasimos Aravantinos; Charalambos Kalofonos; N Timotheadou; V Siafaka; I Vlahou; D Janinis; Dimitrios Pectasides; Nicholas Pavlidis; George Fountzilas
Prevention of anemia in patients with solid tumors receiving platinum-based chemotherapy by recombinant human Erythropoietin (rHuEpo): a prospective, open label, randomized trial by the Hellenic Cooperative Oncology Group.
Oncology 2003;64(2):102-10.
2002: Eleni Galani; Joseph Sgouros; Chariklia Petropoulou; Jim Janinis; Gerasimos Aravantinos; Dionysia Dionysiou-Asteriou; Dimosthenis Skarlos; Efstathios S Gonos
Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.
Anticancer research 2002;22(4):2275-80.
2002: Meletios A Dimopoulos; Christos A Papadimitriou; Kyrillos Sarris; Gerasimos Aravantinos; Charalambos Kalofonos; Dimitra Gika; Georgios M Gourgoulis; Eleni Efstathiou; Dimosthenis Skarlos; Dimitrios Bafaloukos
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group.
Gynecologic oncology 2002;85(3):476-82.
2002: Eleni Andreopoulou; Demetrios M Andreopoulos; Konstantinos Adamidis; A Fountzila-Kalogera; George Fountzilas; Meletios A Dimopoulos; Gerasimos Aravantinos; N Zamboglou; D Baltas; Nicholas Pavlidis
Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer.
Anticancer research 2002;22(3):1903-8.
2002: Haralabos P Kalofonos; Costas Nicolaides; Epaminondas Samantas; Nicolas Mylonakis; Gerasimos Aravantinos; Meletios A Dimopoulos; Constantinos Gennatas; George Kouvatseas; Eleftherios Giannoulis; Christos Dervenis; George Basdanis; Nicholas Pavlidis; Ioannis Androulakis; George Fountzilas
A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
American journal of clinical oncology 2002;25(1):23-30.
2002: Dimitrios Bafaloukos; Gerasimos Aravantinos; George Fountzilas; George P Stathopoulos; Helen Gogas; G Samonis; Evangelos Briasoulis; Nicolas Mylonakis; Dimosthenis V Skarlos; Paris A Kosmidis
Docetaxel in combination with dacarbazine in patients with advanced melanoma.
Oncology 2002;63(4):333-7.
2002: Christos Bacoyiannis; Meletios A Dimopoulos; Haralabos P Kalofonos; Costas Nicolaides; Gerasimos Aravantinos; Dimitrios Bafaloukos; Georgios Fotios Samelis; Adimchi Onyenadum; Christos Kiamouris; Dimosthenis Skarlos; Nicholas Pavlidis; A Triantafillidis; Paris A Kosmidis
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trials.
Oncology 2002;63(2):130-8.
2001: Dimitrios Pectasides; Gerasimos Aravantinos; Haralambos Kalofonos; Christos Kiamouris; Dimitrios Bafaloukos; Nikolaos Xiros; Costas Nicolaides; A Visvikis; Meletios A Dimopoulos
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(10):1417-22.
2001: Pavlos Papakostas; Charalambos Kouroussis; Nikolaos Androulakis; Georgios Fotios Samelis; Gerasimos Aravantinos; Kostas Kalbakis; Evanthia Sarra; John Souglakos; Stylianos Kakolyris; Vassilis Georgoulias
First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.
European journal of cancer (Oxford, England : 1990) 2001;37(15):1833-8.
2001: George Fountzilas; Christos Papadimitriou; Urania Dafni; Dimitrios Bafaloukos; Dimosthenis Skarlos; Lia A Moulopoulos; Evangelia Razis; Haralabos P Kalofonos; Gerasimos Aravantinos; Evangelos Briassoulis; Pavlos Papakostas; K Abela; E Gogas; Paris A Kosmidis; Nicholas Pavlidis; Meletios A Dimopoulos
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2232-9.
2001: George Fountzilas; Christos Papadimitriou; Gerasimos Aravantinos; Costas Nicolaides; George P Stathopoulos; Dimitrios Bafaloukos; Haralambos Kalofonos; T Ekonomopoulos; Dimosthenis Skarlos; Nicholas Pavlidis; Athanassios Meletios Dimopoulos
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer.
Oncology 2001;60(3):214-20.
2001: George P Stathopoulos; Dimitris Mavroudis; Nicolas Tsavaris; Charalambos Kouroussis; Gerasimos Aravantinos; Sofia Agelaki; Stylianos Kakolyris; Sotiris K Rigatos; Spyros Karabekios; Vassilis Georgoulias
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):101-3.
2000: Nicolas Tsavaris; Dimosthenis Skarlos; Christos Bacoyiannis; Gerasimos Aravantinos; Christos Kosmas; George Retalis; Christos Panopoulos; Maria Vadiaka; Antonios Dimitrakopoulos; K Kostantinidis; Dionisios Mitropoulos; Dimitrios A Bougas; Dimitrios Pantazopoulos; Paris A Kosmidis
Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2000;20(8):685-90.
2000: Meletios A Dimopoulos; Christos A Papadimitriou; Vassilis Georgoulias; Lia A Moulopoulos; Gerasimos Aravantinos; Dimitra Gika; S Karpathios; Stamatios F Stamatelopoulos
Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study.
Gynecologic oncology 2000;78(1):52-7.
2000: Gerasimos Aravantinos; Meletios A Dimopoulos; Paris A Kosmidis; Dimitrios Bafaloukos; Christos Papadimitriou; Christos Kiamouris; Nicholas Pavlidis; K Sikiotis; Pavlos Papakostas; Dimosthenis V Skarlos
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(5):607-12.
2000: Jim Janinis; Eleni Efstathiou; Christos Panopoulos; Epaminondas Samantas; Gerasimos Aravantinos; Christos Christodoulou; Dimosthenis Skarlos
Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status.
Medical oncology (Northwood, London, England) 2000;17(2):106-10.
2000: Dimitrios Pectasides; Theofanis Economopoulos; George Kouvatseas; A Antoniou; Z Zoumbos; Gerasimos Aravantinos; Costas Tsatalas; A Halikia; Costas Nikolaides; Christos Kiamouris; E Pappa; Nicholas Pavlidis; Dimosthenis Skarlos; George Fountzilas; Meletios A Dimopoulos
Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: the hellenic cooperative oncology group experience.
Oncology 2000;58(4):286-92.
2000: George Fountzilas; A Zisiadis; Urania Dafni; Christos Konstantaras; G Hatzitheoharis; Spiros Papavramidis; A Bousoulegas; George Basdanis; Eleftherios Giannoulis; J Dokmetzioglou; C Katsohis; E Nenopoulou; N Karvounis; Evangelos Briassoulis; Gerasimos Aravantinos; Paris A Kosmidis; Dimosthenis Skarlos; Nicholas Pavlidis
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Oncology 2000;58(3):227-36.
2000: George Fountzilas; Costas Nicolaides; Dimitrios Bafaloukos; Anna Kalogera-Fountzila; Haralambos Kalofonos; Georgios Fotios Samelis; Gerasimos Aravantinos; Nicholas Pavlidis
Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II study.
Cancer investigation 2000;18(6):503-9.
1999: Gerasimos Aravantinos; Dimosthenis V Skarlos; Paris A Kosmidis; V Georgoulias; I Sgouros; Dimitrios Bafaloukos; N Androulakis; S Florou; George Fountzilas
Irinotecan (CPT-11) in patients with advanced colorectal cancer previously treated with 5-fluorouracil-based chemotherapy.
Critical reviews in oncology/hematology 1999;32(3):209-19.
1999: Meletios A Dimopoulos; Chris N Bakoyannis; Vassilis Georgoulias; Christos Papadimitriou; Lia A Moulopoulos; Charalambos Deliveliotis; A Karayannis; Ioannis M Varkarakis; Gerasimos Aravantinos; Anastasios Zervas; Dimitrios Pantazopoulos; George Fountzilas; Aristotelis Bamias; Zacharias Kyriakakis; Athanasios Anagnostopoulos; Aris Giannopoulos; Paris A Kosmidis
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1385-8.
1999: Dimitrios Pectasides; Gerasimos Aravantinos; A Visvikis; Charalambos Bakoyiannis; A Halikia; Charalambos Kalofonos; Paris A Kosmidis; Dimosthenis Skarlos; George Fountzilas
Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
Oncology 1999;57(1):1-9.
1999: Nikolaos Androulakis; Charalabos Kourousis; Meletios A Dimopoulos; Georgios Fotios Samelis; Stylianos Kakolyris; Nicolas Tsavaris; K Genatas; Gerasimos Aravantinos; Christos Papadimitriou; Spyros Karabekios; George P Stathopoulos; Vassilis Georgoulias
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1779-85.
1999: Dimitrios Bafaloukos; Gerasimos Aravantinos; G Samonis; G Katsifis; Charalambos Bakoyiannis; Dimosthenis Skarlos; Paris A Kosmidis
Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic cooperative oncology group study.
Oncology 1999;56(3):198-201.
1998: George Fountzilas; Costas Nicolaides; Gerasimos Aravantinos; Dimosthenis Skarlos; Paris A Kosmidis; Pavlos Papakostas; George P Stathopoulos; E Kontostolis; Dimitrios Bafaloukos; Nicholas Pavlidis
Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and >/=10 positive axillary lymph nodes. A feasibility study.
Oncology 1998;55(6):508-12.
1998: George Fountzilas; Athanassios Meletios Dimopoulos; Christos Papadimitriou; Anna Kalogera-Fountzila; Gerasimos Aravantinos; Dimitrios Bafaloukos; A Athanassiades; Costas Nicolaides; A Keramopoulos; Nicholas Pavlidis; Paris A Kosmidis; Dimosthenis Skarlos
First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): a phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):1031-4.
1998: Meletios A Dimopoulos; Marianna Papadopoulou; Eleni Andreopoulou; Christos Papadimitriou; Nicholas Pavlidis; Gerasimos Aravantinos; A Aspropotamitis; A Anagnostopoulos; George Fountzilas; Stylianos Michalas; D Pectacides
Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
Gynecologic oncology 1998;70(1):70-4.
1998: George Fountzilas; A Athanassiades; V Papadimitriou; Meletios A Dimopoulos; Dimitrios Bafaloukos; Gerasimos Aravantinos; Costas Nicolaides; Haralambos Kalofonos; Pavlos Papakostas; Nikolaos Xiros; Evangelia Razi
Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer.
Oncology (Williston Park, N.Y.) 1998;12(1 Suppl 1):45-8.
1997: Meletios A Dimopoulos; Christos Panopoulos; Christina Bamia; Charalambos Deliveliotis; Gerasimos Alivizatos; Dimitrios Pantazopoulos; C Constantinidis; Athanasios Kostakopoulos; Ioannis Kastriotis; Anastasios Zervas; Gerasimos Aravantinos; Constantinos Dimopoulos
Oral estramustine and oral etoposide for hormone-refractory prostate cancer.
Urology 1997;50(5):754-8.
1997: George Fountzilas; AP Athanassiadis; Anna Kalogera-Fountzila; Gerasimos Aravantinos; Dimitrios Bafaloukos; Evangelos Briasoulis; Nicholas V Dombros; Ioannis Ioannidis; Nicholas Pavlidis; Paris A Kosmidis; Dimosthenis Skarlos
Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group.
European journal of cancer (Oxford, England : 1990) 1997;33(11):1893-5.
1997: Dimosthenis V Skarlos; Gerasimos Aravantinos; Paris A Kosmidis; AP Athanassiadis; George P Stathopoulos; Nicholas Pavlidis; Dimitrios Bafaloukos; S Karphathios; Pavlos Papakostas; Christina Bamia; George Fountzilas
Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Seminars in oncology 1997;24(5 Suppl 15):S15-57-S15-61.
1997: Eleni Petridou; K I Roukas; Nick Dessypris; Gerasimos Aravantinos; Dimitrios Bafaloukos; A Efraimidis; A Papacharalambous; D Pektasidis; Gerasimos Rigatos; Dimitrios Trichopoulos
Baldness and other correlates of sex hormones in relation to testicular cancer.
International journal of cancer. Journal international du cancer 1997;71(6):982-5.
1997: Paris A Kosmidis; Christos Bacoyiannis; George Fountzilas; Gerasimos Aravantinos; Nicolas Tsavaris; C Milathianakis; Dimosthenis Skarlos
5-Fluorouracil, interferon-alpha-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Hellenic Co-operative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(4):373-8.
1997: Dimosthenis V Skarlos; Gerasimos Aravantinos; E Linardou; C A Kostakopoulos; Ioannis Kastriotis; Christos Christodoulou; D Picramenos; THEODORE GIANNAKAKIS; K Dimopoulos; George Fountzilas
Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group study.
European urology 1997;31(4):420-7.
1997: Gerasimos Aravantinos; Dimosthenis V Skarlos; Paris A Kosmidis; A Athanassiades; Dimitrios Bafaloukos; THEODORE GIANNAKAKIS; S Karpathios; George Fountzilas
A phase II study of paclitaxel in platinum pretreated ovarian cancer. A Hellenic Cooperative Oncology Group study.
European journal of cancer (Oxford, England : 1990) 1997;33(1):160-3.
1996: D V Skarlos; Gerasimos Aravantinos; Paris A Kosmidis; Nicholas Pavlidis; K Gennatas; M Beer; Nicolas Mylonakis; P Makrantonakis; George Klouvas; S Karpathios; H Linardou; Christos Konstantaras; George Fountzilas
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group study.
European journal of cancer (Oxford, England : 1990) 1996;32A(3):421-8.
1993: D V Skarlos; George Fountzilas; Nicholas Pavlidis; M Beer; P Makrantonakis; Gerasimos Aravantinos; P Pantelakos; Nicolas Tsavaris; N Karpasitis; Paris A Kosmidis
Megestrol acetate in cancer patients with anorexia and weight loss. A Hellenic Co-operative Oncology Group (HeCOG) study.
Acta oncologica (Stockholm, Sweden) 1993;32(1):37-41.
1990: E Anagnostaki; D Skarlos; N Tamvakis; P Psaropoulou; E Blana; A Bamias; S Legaki; Gerasimos Aravantinos; Charalambos Deliveliotis; K Dimopoulos
Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
The British journal of cancer. Supplement 1990;10():52-6.
1990: Athanasios Kostakopoulos; Charalambos Deliveliotis; E Mavromanolakis; Gerasimos Aravantinos; Meletios A Dimopoulos
Intravesical interferon alfa-2b administration in the treatment of superficial bladder tumors.
European urology 1990;18(3):201-3.
1988: J Malamitsi; D Skarlos; S Fotiou; Pavlos Papakostas; Gerasimos Aravantinos; D Vassilarou; J Taylor-Papadimitriou; K Koutoulidis; G Hooker; D Snook
Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(12):1910-5.
1988: S Fotiou; D Skarlos; Aliki Tserkezoglou; Gerasimos Aravantinos; J Malamitsi; K Koutoulidis
Monoclonal antibodies in ovarian tumor imaging.
European journal of gynaecological oncology 1988;9(4):304-7.